NCT00861861

Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)

Comparison of Pitavastatin With Atorvastatin in Increasing HDL-C and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 129 (actual)
• Sponsor: Kumamoto University · Academic / Other
• Sex: All
• Age: 20 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the effects of pitavastatin and atorvastatin on adiponectin percentage change in patients with hypercholesteremia comorbid stable CAD.

Detailed description

The efficiency of lipid lowering therapy was already proven by the clinical trials of statins. According to these results, the target value of LDL-C is recommended under 100mg/dL in the Japan Atherosclerosis Society Guidelines. However, the efficiency of intensive therapy to lower LDL-C more than 100mg/dL has not been proven yet.

Conditions

• Hypercholesterolemia
• Coronary Artery Disease

Interventions

Type	Name	Description
DRUG	Pitavastatin	comparison of two drugs in increasing HDL-C and adiponectin
DRUG	Atorvastatin	comparison of two drugs in increasing HDL-C and adiponectin

Timeline

• Start date: 2008-09-01
• Primary completion: 2013-10-01
• Completion: 2013-10-01
• First posted: 2009-03-16
• Last updated: 2013-10-14

Locations

1 site across 1 country: Japan